News Archive

DCRI Executive Director Adrian Hernandez, MD, MHS, called for a platform that will enable clinical research to be embedded into patient care, allowing research to be conducted at patients’ homes.

Results suggest that a subset of high-risk patients may benefit from an initial invasive treatment strategy.

A wide range of stakeholders who attended an April 2019 DCRI Think Tank helped to identify current challenges to developing treatments for chronic kidney disease, as well as make recommendations for strategies to address these challenges.

Since its inception in 2015, the CARRA Registry, for which the DCRI serves as the coordinating center, has provided necessary infrastructure and data to support a wide range of clinical research projects.

Even in the midst of a global pandemic, taking the time to conduct randomized controlled trials is the most rigorous way to build evidence for potential treatments, according to a recent opinion pi

A group of current and former DCRI researchers contributed to a paper in JACC warning against relying on observational data to guide clinical decisions.

EDITORS’ NOTE (Dec. 2020): This story has been updated to reflect the ABC Science Collaborative’s new name.

Attendees to a January 2019 DCRI Think Tank outlined recommendations for optimizing pragmatic clinical trials and weighing risks and benefits of innovative trial designs.

An analysis of a study called Mission: Lifeline STEMI Accelerator II found that when patients experiencing an ST-elevation myocardial infarction present in facilities not capable of performing percutaneous intervention, the time between their arrival and cath lab activation is an important quality metric to direct timely reperfusion.

Seven DCRI faculty participated in the June 24 event, which shared a range of Duke research projects and nationwide collaborative efforts geared toward addressing COVID-19 and racial and ethnic hea